Most Popular Activities

This program will address the clinical challenge of managing refractory Gout. Content focuses on pathophysiologic concepts and their relationship to current strategies for promoting positive outcomes. Take this activity here!

Supported by an educational grant from Horizon Pharma

 

 

Most Popular Activities

Renal cell carcinoma (RCC) is the most common type of kidney cancer and is responsible for about 90% of all primary renal neoplasms. Additionally, RCC is associated with an increased risk for chronic kidney disease (CKD) and kidney failure. CKD in cancer survivors increases the long-term risk for cardiovascular morbidity and mortality. Significant advances in treating RCC have occurred within the past 10 years, including targeted therapies and multiple immuno-oncology (IO) agents. 

This program will inform learners on guidelines for kidney cancer and enable clinicians stay informed of the evolving treatment landscapes for RCC. Take it today here!

 

Most Popular Activities

This program will share updates on the most recent advances relevant to the role of decreased kidney function and ancillary comorbid conditions in the development of hyperkalemia, the association of hyperkalemia with adverse outcomes, and the currently available treatment regimens for acute and chronic hyperkalemia management and their potential impact on outcomes such as quality control measures and patient satisfaction. Take it today!

Supported by an educational donation provided by AstraZeneca Pharmaceuticals LP. 

 

Most Popular Activities

This activity presents the current evidence and positions both for and against the use of RRT in patients with HRS/AKI; participants will be presented with some patient scenarios and challenged to vote on whether they believe RRT would be beneficial in these patients. Take the activity here!

Supported by an educational donation provided by Mallinckrodt Pharmaceuticals

 

Most Popular Activities

This program addresses the clinical challenge of preventing and treating anemia in patients with chronic kidney disease (CKD). Faculty discuss factors that contribute to the pathogenesis, as well as the symptoms, risks, and outcomes associated with CKD-related anemia. The program will also explore current and emerging strategies for managing anemia in patients with CKD. Take the activity here!

Supported by an educational grant from AstraZeneca Pharmaceuticals

 

Upcoming Events

September 2019

Titlesort ascending Date
51st Annual Medical Symposium 09/27/2019 - 8:00am to 4:30pm

NKF Members get the best PERCs

Not a member? Become one today!

And get FREE access to take all online CME/CE courses 

Frequently Asked Questions

FAQ

Transcript

Please login or create an account to view your activities.

CME Program Mission Statement

The mission of the National Kidney Foundation (NKF) Continuing Education (CE) Program is to assist members of the interprofessional healthcare team in nephrology and other specialties impacted by kidney disease in their pursuit of life-long learning toward providing high quality healthcare. See More…

CME Program Accreditation

NKF has been granted Joint Accreditation status by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE) and American Nurses Credentialing Center (ANCC) to provide accredited continuing education for the healthcare team.

NKF is also accredited by the Commission on Dietetic Registration (CDR) and the Association of Social Work Boards (ASWB) as a provider of continuing education for dieticians and socials workers.